Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zomedica Corp. ZOM

Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is currently focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments: Diagnostic & Therapeutics. It earns the majority of revenue from the therapeutics segment.

Recent & Breaking News (NYSEAM:ZOM)

Zomedica Announces 2021 Annual Meeting Results

GlobeNewswire July 30, 2021

Zomedica Provides Corporate Update

GlobeNewswire July 6, 2021

Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts

GlobeNewswire May 17, 2021

Zomedica Announces First Quarter 2021 Financial Results

GlobeNewswire May 12, 2021

Zomedica Announces First Commercial Sale of Its Truforma® Platform

GlobeNewswire March 16, 2021

Zomedica Retires Preferred Shares

GlobeNewswire March 8, 2021

Zomedica Corp. Announces Year End 2020 Financial Results

GlobeNewswire February 26, 2021

Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter

GlobeNewswire February 16, 2021

Zomedica Corp. Announces Closing of $173.5 Million Bought Deal

GlobeNewswire February 11, 2021

Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million

GlobeNewswire February 8, 2021

Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares

GlobeNewswire February 8, 2021

Zomedica Signs TRUFORMA(TM) Distribution Agreement With Miller Veterinary Supply

GlobeNewswire January 25, 2021

Zomedica CEO Issues Shareholder Letter as TRUFORMA(TM) Nears Commercialization

GlobeNewswire January 18, 2021

Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA(TM)

GlobeNewswire January 4, 2021

Zomedica to Remain Domiciled in Canada

GlobeNewswire December 15, 2020

Zomedica Completes Internal "Launch Team" for Upcoming TRUFORMA(TM) Commercialization

GlobeNewswire December 7, 2020

Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA(TM)

GlobeNewswire November 13, 2020

Zomedica Announces Third Quarter 2020 Financial Results

GlobeNewswire November 12, 2020

Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting

GlobeNewswire October 26, 2020

Zomedica Announces Name Change

GlobeNewswire October 2, 2020